These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8964860

  • 21. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
    Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C.
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4471-8. PubMed ID: 18728158
    [Abstract] [Full Text] [Related]

  • 22. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ, Crampton LJ, Freund J, Ho KK.
    J Clin Invest; 1998 Sep 01; 102(5):1035-40. PubMed ID: 9727072
    [Abstract] [Full Text] [Related]

  • 23. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.
    van den Berg G, Veldhuis JD, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1996 Jul 01; 81(7):2460-7. PubMed ID: 8675561
    [Abstract] [Full Text] [Related]

  • 24. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR, Toogood AA, Veldhuis JD, Thorner MO, Shalet SM.
    J Clin Endocrinol Metab; 2001 Jan 01; 86(1):259-66. PubMed ID: 11232010
    [Abstract] [Full Text] [Related]

  • 25. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ, Ho KK.
    J Clin Endocrinol Metab; 1995 Jun 01; 80(6):1783-8. PubMed ID: 7775623
    [Abstract] [Full Text] [Related]

  • 26. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 01; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 27. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus.
    Asplin CM, Faria AC, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS.
    J Clin Endocrinol Metab; 1989 Aug 01; 69(2):239-45. PubMed ID: 2753972
    [Abstract] [Full Text] [Related]

  • 28. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 01; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 29. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA, Biermasz NR, Zelissen PM, Pereira AM, Lentjes EG, Smit JW, van Thiel SW, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2007 Dec 01; 157(6):709-16. PubMed ID: 18057377
    [Abstract] [Full Text] [Related]

  • 30. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Dec 01; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 31. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 01; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1996 Aug 01; 81(8):2874-80. PubMed ID: 8768844
    [Abstract] [Full Text] [Related]

  • 33. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.
    Hartman ML, Veldhuis JD, Vance ML, Faria AC, Furlanetto RW, Thorner MO.
    J Clin Endocrinol Metab; 1990 May 01; 70(5):1375-84. PubMed ID: 2335577
    [Abstract] [Full Text] [Related]

  • 34. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
    Veldhuis JD, Anderson SM, Kok P, Iranmanesh A, Frystyk J, Ørskov H, Keenan DM.
    J Clin Endocrinol Metab; 2004 Mar 01; 89(3):1312-8. PubMed ID: 15001627
    [Abstract] [Full Text] [Related]

  • 35. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U.
    Clin Cancer Res; 2004 Jul 01; 10(13):4389-97. PubMed ID: 15240527
    [Abstract] [Full Text] [Related]

  • 36. Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion.
    Shah N, Evans WS, Veldhuis JD.
    Am J Physiol; 1999 May 01; 276(5):R1351-8. PubMed ID: 10233027
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
    Uhler ML, Marks JW, Voigt BJ, Judd HL.
    J Clin Endocrinol Metab; 1998 Feb 01; 83(2):410-4. PubMed ID: 9467549
    [Abstract] [Full Text] [Related]

  • 38. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
    Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S.
    J Clin Endocrinol Metab; 1995 Nov 01; 80(11):3209-22. PubMed ID: 7593428
    [Abstract] [Full Text] [Related]

  • 39. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A, Castelo-Branco C, Tarín JJ.
    Fertil Steril; 1999 Feb 01; 71(2):261-7. PubMed ID: 9988395
    [Abstract] [Full Text] [Related]

  • 40. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Feb 01; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.